Skip to main content
Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
41.32
0.00 (0.00%)
At close: Mar 4, 2026

BIOVF Revenue

In the year 2025, Swedish Orphan Biovitrum AB had annual revenue of 28.24B SEK with 8.50% growth. Swedish Orphan Biovitrum AB had revenue of 7.82B in the quarter ending December 31, 2025, with 5.19% growth.

Revenue
28.24B SEK
Revenue Growth
+8.50%
P/S Ratio
4.62
Revenue / Employee
14.96M SEK
Employees
1,888
Market Cap
14.15B USD

Revenue Chart

* This company reports financials in SEK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202528.24B2.21B8.50%
Dec 31, 202426.03B3.90B17.65%
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Glass House Brands 196.17M
Elite Pharmaceuticals 140.12M
Jushi Holdings 260.43M
Growth Stalk Holdings 583.34K
Sofgen Pharma 423.75M
Radnostix 14.07M
Healthy Extracts 3.59M
MariMed 157.38M
Revenue Rankings

Swedish Orphan Biovitrum AB News

More News